This trade is where big investors are hiding out amid choppy markets, Goldman Sachs says

This trade is where big investors are hiding out amid choppy markets, Goldman Sachs says


A Goldman Sachs Group Inc. logo hangs on the floor of the New York Stock Exchange in New York, U.S., on Wednesday, May 19, 2010.

Daniel Acker | Bloomberg | Getty Images

Investors have piled into short-term U.S. government bonds in a bid to wait out the upheaval caused by a blowout in longer-term yields, according to a Goldman Sachs executive.

An auction this week of 52-week Treasury bills at a 5.19% rate was 3.2 times oversubscribed, its highest demand of the year, said Lindsay Rosner, head of multi-sector investing at Goldman Sachs asset and wealth management.

“They’re saying, ‘I’m now being afforded a lot more yield in the very front end of the curve in government paper’,” Rosner told CNBC in a phone interview, referring to 1-year T-bills. “That is really where you’re seeing investors flock.”

The trade is a key way that institutions and wealthy investors are adjusting to the surge in long-term interest rates that have roiled markets lately. The 10-year Treasury yield has been climbing for weeks, reaching a 16-year high of 4.89% Friday after the September jobs report showed that employers were still hiring aggressively. Investors poured more than $1 trillion into new T-bills last quarter, according to Bloomberg.

The playbook, according to Rosner, takes advantage of the presumption that interest rates will be higher for longer than markets had expected earlier this year. If that sentiment holds true, longer-duration Treasuries like the 10-year should offer better yields next year as the yield curve steepens, she said.

“You get to collect a 5% coupon for the next year,” she said. “Then, in a year, you may have opportunities [in longer-duration Treasuries] at greater than 5% in government securities or potentially in [corporate bonds] that are now properly priced.

“You could then get a double-digit yield, but be confident about valuation, unlike now,” she added.

While 10-year Treasuries have crashed in recent weeks, other fixed income instruments including investment-grade and high-yield bonds haven’t fully reflected the change in rate assumptions, according to Rosner. That makes them a bad deal for the moment, but could create opportunities down the road.

The upheaval that’s punished holders of longer-dated Treasuries in recent weeks has professional managers reducing the average duration of their portfolios, according to Ben Emons, head of fixed income at NewEdge Wealth. 

“Treasury bills are in high demand,” he said. “Anyone out there who needs to manage duration in their portfolio, you do that with the 1-year T bill. That’s what BlackRock is doing, it’s what I’m doing.”



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More